Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Alan Korman

15PUBLICATIONS
146CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Epidemiological modellingTumour immunologyMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

Sort by Publication Date:
|Mar 16, 2026
Improving anti-CTLA-4 therapies through peptide masking and fragment crystallizable non‑fucosylation: preclinical characterization of three novel antibodies.

Amy Jhatakia, Xin Sun, Alessandra Vaccaro

|Jan 30, 2026
Cross-species cellular mapping and humanization of Fcγ receptors to advance antibody modeling.

Karel F A Van Damme, Dorine Sichien, Katrien Van der Borght

|Nov 17, 2025
Endothelial cells as targets of immune checkpoint blockade.

Alan J Korman, Matthew Taylor, F Stephen Hodi

|May 10, 2024
CD8<sup>+</sup> T cell targeting of tumor antigens presented by HLA-E.

Ravi F Iyer, Marieke C Verweij, Sujit S Nair

|Aug 18, 2022
Preclinical Characterization of Relatlimab, a Human LAG-3-Blocking Antibody, Alone or in Combination with Nivolumab.

Kent Thudium, Mark Selby, Julie A Zorn

|Jan 15, 2022
Author Correction: The foundations of immune checkpoint blockade and the ipilimumab approval decennial.

Alan J Korman, Sarah C Garrett-Thomson, Nils Lonberg

Pageof 3

Frequent Collaborators

3 joint publications

Mark Selby

2 joint publications

Nils Lonberg

1 joint publications

Lauren Lever

1 joint publications

Jacob Slowinski

1 joint publications

Tyler J Van De Voort

1 joint publications

Stephen D Gillies

1 joint publications

Megan M Tu

1 joint publications

Abigail K Kimball

1 joint publications

Tina Cascone

1 joint publications

Krista Menard

Frequent Collaborators

3 joint publications

Mark Selby

2 joint publications

Nils Lonberg

1 joint publications

Lauren Lever

1 joint publications

Jacob Slowinski

Top Related Videos

Targeted Antibody Blocking by a Dual-Functional Conjugate of Antigenic Peptide and Fc-III Mimetics (DCAF)
09:39

Targeted Antibody Blocking by a Dual-Functional Conjugate of Antigenic Peptide and Fc-III Mimetics (DCAF)

Published on : Sep 17, 2019

7.4K
Use of a Monocyte Monolayer Assay to Evaluate Fc&#947; Receptor-mediated Phagocytosis
06:27

Use of a Monocyte Monolayer Assay to Evaluate Fc&#947; Receptor-mediated Phagocytosis

Published on : Jan 02, 2017

18.8K
Screening Assays to Characterize Novel Endothelial Regulators Involved in the Inflammatory Response
12:50

Screening Assays to Characterize Novel Endothelial Regulators Involved in the Inflammatory Response

Published on : Sep 15, 2017

6.9K
See more related videos

Top Related Videos

Targeted Antibody Blocking by a Dual-Functional Conjugate of Antigenic Peptide and Fc-III Mimetics (DCAF)
09:39

Targeted Antibody Blocking by a Dual-Functional Conjugate of Antigenic Peptide and Fc-III Mimetics (DCAF)

Published on : Sep 17, 2019

7.4K
Use of a Monocyte Monolayer Assay to Evaluate Fc&#947; Receptor-mediated Phagocytosis
06:27

Use of a Monocyte Monolayer Assay to Evaluate Fc&#947; Receptor-mediated Phagocytosis

Published on : Jan 02, 2017

18.8K
Screening Assays to Characterize Novel Endothelial Regulators Involved in the Inflammatory Response
12:50

Screening Assays to Characterize Novel Endothelial Regulators Involved in the Inflammatory Response

Published on : Sep 15, 2017

6.9K
See more related videos